✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹1,524 Cr.
P/E
35.49

Key Ratios

Market cap
Market cap
1,524 Cr
PE
PE
35.49
Prom Holding
Prom Holding
59.19 %
ROE (%)
ROE (%)
-30.10
ROCE (%)
ROCE (%)
16.82
Div Yield (%)
Div Yield (%)
0.21
Sales
Sales
542 Cr
OPM (%)
OPM (%)
15.19 %
Debt to Equity
Debt to Equity
1.19
About
Bajaj Healthcare Ltd mainly focuses on development, manufacturing and supply of Amino Acids, N… Read more
Low
313
52W Range
High
745
  • Bajaj Healthcare
  • Hester Biosciences
  • Themis Medicare
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Bajaj Healthcare Ltd. Business

    Bajaj Healthcare Ltd specializes in producing Amino Acids, Nutritional Supplements, and Active Pharmaceutical Ingredients for Pharmaceutical, Nutraceuticals, and Food industries, offering a wide range of products.

    Bajaj Healthcare major competitors are Hester Biosciences, Themis Medicare, SMS Pharmaceuticals, Kopran, Shree Ganesh Remed., NGL Fine-Chem, Nectar Lifesciences.
    Market Cap of Bajaj Healthcare is ₹1,594 Crs.
    While the median market cap of its peers are ₹910 Crs.

    Bajaj Healthcare seems to be less financially stable compared to its competitors.
    Altman Z score of Bajaj Healthcare is 3.37 and is ranked 7 out of its 8 competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May Mar Jun Sep Jun Sep Dec Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Mar Jun
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material